M
Marc Carrier
Researcher at Ottawa Hospital Research Institute
Publications - 396
Citations - 17092
Marc Carrier is an academic researcher from Ottawa Hospital Research Institute. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 58, co-authored 325 publications receiving 12428 citations. Previous affiliations of Marc Carrier include Ottawa Hospital & University of Ottawa.
Papers
More filters
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
TL;DR: A.A. Khorana et al. as discussed by the authors, S. A. NoBLE, S. Y. Lee, G. G. MEYER, C. O'CONNELL and M. CARR IER.
Journal ArticleDOI
The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety
Ryma Ihaddadene,Marc Carrier +1 more
TL;DR: This narrative review addresses the safety of unfractionated heparin, low-molecular-weight heparins, fondaparinux, warfarin and direct oral anticoagulants (DOAC) in obese patients and recommends weight-based dosing of UFH and LMWH over fixed dosing in most obese patients for VTE treatment and prophylaxis.
Journal ArticleDOI
Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
Sarah Chibane,Guillaume Gibeau,Frédéric Poulin,Pierre Tessier,Michelle Goulet,Marc Carrier,Sylvain Lanthier +6 more
TL;DR: It is reported that COVID-19-associated hyperacute multi-organ thromboembolic storm may precede or present disproportionately to respiratory involvement, and the concept of coronavirus infection of endothelial cells and hypercoagulability, or CO VID-19 endotheliitis is supported.
Journal ArticleDOI
Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis.
Noémie Kraaijpoel,Marc Carrier,Marc Carrier,Marc Carrier,Grégoire Le Gal,Grégoire Le Gal,Grégoire Le Gal,Matthew D. F. McInnes,Matthew D. F. McInnes,Jean-Paul Salameh,Trevor A. McGrath,Nick van Es,David Moher,David Moher,Harry R. Büller,Patrick M.M. Bossuyt,Mariska M.G. Leeflang +16 more
TL;DR: The failure rates of single limited, serial limited, and whole-leg CUS for DVT appeared to be quite comparable, as the DVT prevalence was lower in these studies, and this CUS strategy may only be safe in a selected group of low-risk patients.
Journal ArticleDOI
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis.
Nick van Es,Grégoire Le Gal,Hans Martin Otten,Philippe Robin,Andrea Piccioli,Ramón Lecumberri,Luis Jara Palomares,Piotr Religa,Viriginie Rieu,Matthew T. Rondina,Mariëlle Beckers,Paolo Prandoni,Pierre Salaun,Marcello Di Nisio,Patrick M. Bossuyt,Harry R. Büller,Marc Carrier +16 more
TL;DR: A systematic review and individual patient data meta-analysis of protocol-mandated screening for cancer in patients with unprovoked VTE and with at least 12 months’ follow-up to provide clinicians and other decision-makers with valid and precise risk estimates of occult cancer.